Insilico Medicine Reports Initial Efficacy Signals for ISM6331 in Phase I
Insilico Medicine reported initial indications of efficacy for ISM6331 in a Phase I study in mesothelioma.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.